You are here: Industry Insights > Hormone therapy

News List

New Hormonal Pill May Boost Outcomes for Older Breast Cancer Patients Drugs
December 08, 2021
An experimental hormone therapy pill can effectively stall the progression of breast cancer, even in older patients whose tumors have mutated to make such therapy less effective, new trial results show.
Could Menopausal Hormone Therapy Reduce Women's Odds for Dementia? drugs
July 21, 2021
Women on hormone replacement therapy (HRT) for menopause go on to have a 58% lower risk of Alzheimer's disease and other neurodegenerative conditions, a new study finds.
AHA News: At 17, He Received a New Heart. By 23, He Began Transitioning drugs
June 21, 2021
For most transgender people, starting hormone therapy requires a therapist's approval.
Oral hormone therapy found to alter metabolome of postmenopausal women europeanpharmaceuticalreview
December 18, 2020
Research has shown oral hormone therapy significantly impacts the metabolome of postmenopausal women, explaining certain disease risks.
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy En-CPhI.CN
October 10, 2019
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer.
Hormone therapy helps reduce hyperkyphosis europeanpharmaceuticalreview
February 28, 2018
The Women’s Health Initiative have found that hormone therapy use was associated with a reduction in vertebral fracture risk…
Health Canada accepts marketing application for Mithra’s hormone therapy Tibelia pharmaceufical-technology
October 12, 2017
Health Canada has accepted a marketing authorisation application for the Belgian pharmaceutical company Mithra’s complex therapeutic Tibelia, a tibolone-based product, to be used in hormone therapy (HT).
Mithra signs agreement with Fuji Pharma to commercialise Donesta pharmaceutical-technology
March 06, 2017
Mithra Pharmaceuticals has signed an agreement with Japanese company Fuji Pharma to commercialise its hormonal treatment (HT) product candidate, Donesta, in Japan and Asean.